Teva Pharmaceuticals @TevaUSA
Teva is committed to the research and development of preventive treatment options for patients with #migraine. Today at #AHSAM22 we’re pleased to share late-breaking results from a real-world study in patients using accompanying gepants for acute migraine treatment. #NeuroTwitter — PolitiTweet.org